Hyogo, Japan

Tomoyo Hashiguchi

This inventor holds 1 USPTO granted patent. Top assignees: National Cancer Center, Transgenic Inc.. Active years: 2014.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tomoyo Hashiguchi

Introduction

Tomoyo Hashiguchi is a prominent inventor based in Hyogo, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work has implications for various medical applications, showcasing her expertise and dedication to innovation.

Latest Patents

One of her notable patents is titled "High specificity monoclonal antibody against a protein or a polypeptide having oxidative modification." This invention provides an antibody that reacts specifically with a modified form of fibrinogen (FGA) or its partial peptides, which are hydroxylated at certain proline residues. Importantly, this antibody does not react with unmodified FGA or its partial peptides, highlighting its specificity and potential utility in medical diagnostics and therapeutics. She holds 1 patent in this area.

Career Highlights

Throughout her career, Tomoyo Hashiguchi has worked with esteemed organizations such as Transgenic Inc. and the National Cancer Center. Her roles in these institutions have allowed her to collaborate with leading scientists and contribute to groundbreaking research in her field.

Collaborations

Some of her notable coworkers include Tesshi Yamada and Hiroshi Nose. Their collaborative efforts have further advanced the research and development of innovative solutions in biotechnology.

Conclusion

Tomoyo Hashiguchi's contributions to the field of biotechnology, particularly through her patent on monoclonal antibodies, demonstrate her commitment to innovation and excellence. Her work continues to inspire future advancements in medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…